Literature DB >> 21175369

Quality control and analytical techniques for biopharmaceuticals.

C Jane Robinson1, Christopher Jones.   

Abstract

Biopharmaceuticals are complex products and to ensure their batch-to-batch consistency and continuing quality the use of a combination of complementary analytical tests is required. Regulatory guidelines indicate quality attributes of different product classes to be included in the specifications for product release. Whilst the continuing development of sophisticated physicochemical techniques make them increasingly powerful for defining product identity, integrity, purity and the consistency of the manufacturing process, the results generated are not easily related to the biological activity. Consequently, a bioassay is normally required in the quality control to determine the potency, that is, the quantitative measure of the product's ability to cause a specific biological effect in a defined biological system. A wide, and rapidly increasing, range of bioassay systems exist, each type with particular advantages and disadvantages.

Mesh:

Substances:

Year:  2011        PMID: 21175369     DOI: 10.4155/bio.10.161

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  4 in total

1.  A View on the Importance of "Multi-Attribute Method" for Measuring Purity of Biopharmaceuticals and Improving Overall Control Strategy.

Authors:  Richard S Rogers; Michael Abernathy; Douglas D Richardson; Jason C Rouse; Justin B Sperry; Patrick Swann; Jette Wypych; Christopher Yu; Li Zang; Rohini Deshpande
Journal:  AAPS J       Date:  2017-11-30       Impact factor: 4.009

2.  Analytical characterization of ch14.18: a mouse-human chimeric disialoganglioside-specific therapeutic antibody.

Authors:  Gopalan Soman; Abraham T Kallarakal; Dennis Michiel; Xiaoyi Yang; Nirmala Saptharish; Hengguang Jiang; Steve Giardina; John Gilly; George Mitra
Journal:  MAbs       Date:  2012 Jan-Feb       Impact factor: 5.857

3.  Quantification of Structural Integrity and Stability Using Nanograms of Protein by Flow-Induced Dispersion Analysis.

Authors:  Morten E Pedersen; Jesper Østergaard; Henrik Jensen
Journal:  Molecules       Date:  2022-04-13       Impact factor: 4.927

4.  Size-based characterization of adalimumab and TNF-α interactions using flow induced dispersion analysis: assessment of avidity-stabilized multiple bound species.

Authors:  Morten E Pedersen; Ragna M S Haegebaert; Jesper Østergaard; Henrik Jensen
Journal:  Sci Rep       Date:  2021-02-26       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.